Valneva SE

VALN

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001836564

SEC filings (opens in a new tab)

No open-market purchases or sales by Valneva SE insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $19.8M in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Valneva SE changed between Q3 2023 and Q4 2023.

All holders in Q4 2023 All holders in Q3 2023

13F holders of VALN: Q3 2023 compared with Q4 2023
Measure	Q3 2023	Q4 2023	Change
Holders	10	9	−1
Shares	397.4K	387.0K	−10.4K (−2.6%)
Value	$4.69M	$3.98M	−$705.1K (−15.0%)

New holders (1)

Institutions that held Valneva SE at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to VALN in Q4 2023
Institution	Shares	Value	% of portfolio
Barclays PLC	417	$4.32K	0.00%

Sold out (2)

Institutions that held Valneva SE at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of VALN in Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
Laurion Capital Management LP	25,000	$295.0K
JPMorgan Chase & Co	39	$460